Reagents News and Research

RSS

New CellCelector CLD takes you from thousands of candidates to the top clone, faster

Sartorius announces the launch of the CellCelector CLD, an automated imaging and cell isolation platform designed to simplify and accelerate monoclonal cell line development (CLD).

From Sartorius 10 Apr 2026

Semarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoption

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP).

From Semarion 31 Mar 2026

Collaboration advances EMA601 as potential first-in-class stroke therapy

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody EMA601.

30 Mar 2026

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs).

From Nuclera 30 Mar 2026

New AI system maps gene expression across the whole body

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries that use these technologies only focus on one organ or one small area of tissue.

27 Mar 2026

The new microchip electrophoresis system MultiNA II MCE-301- High sensitivity detection, improved analysis function and operability

Shimadzu has recently released the MultiNA II MCE-301 microchip electrophoresis system. By automating the entire process of electrophoresis, which takes more than two hours by hand (creation of gels, dispensing reagents, dispensing sample, separation, dyeing, cleaning of equipment), the company significantly improves the efficiency of genetic analysis operations.

From Shimadzu Europa GmbH 26 Mar 2026

GC product division celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics

Today, analytica opens its doors in Munich from March 24th to 27th. Shimadzu, a global supplier of analytical measurement and testing equipment, is once again present at the world's leading trade fair – and delighted to be celebrating another anniversary so soon after its 150th birthday last year: the 70th anniversary of its gas chromatography (GC) product line.

From Shimadzu Europa GmbH 26 Mar 2026

New Legionella testing selective agar plates launched by AnalytiChem

AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has launched a new addition to its high-quality Redipor® microbiological prepared media portfolio.

From AnalytiChem 24 Mar 2026

ProImmune and the Roslin Institute collaborate to advance animal health science

ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh's Roslin Institute to advance veterinary immunology research through development and validation of novel species-specific Ankyron® binders.

From ProImmune Ltd. 18 Mar 2026

Circular RNA produced by HIV boosts viral replication

For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen.

13 Mar 2026

Pen-strep treatment rewires mechanical sensing in immune cells

Macrophages are central to mechanobiology research: their physical characteristics-stiffness, adhesion, and ECM (extracellular matrix) sensing-are inextricably linked to their phenotypic polarization and immune function.

13 Mar 2026

Cambridge’s LED breakthrough reinvents drug synthesis

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals – a discovery that could accelerate and improve how medicines are designed and made.

13 Mar 2026

Innovative microscopic capsules overcome long-standing limitations in single-cell research

Researchers have developed a capsule-based method that makes it possible to analyse the same cell through multiple experimental steps.

12 Mar 2026

ELRIG announces Prof Hazel Screen and Dr Dave Powell as keynote speakers for Advances in Cell-Based Screening 2026

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, today announced the keynote speakers for Advances in Cell-based Screening 2026, taking place at AstraZeneca in Gothenburg, Sweden from 6-7 May.

From ELRIG (UK) Ltd. 12 Mar 2026

Boron-assisted reactions overcome solubility barriers in protein synthesis

Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound.

10 Mar 2026

Low-cost interventions reduce neonatal sepsis from Klebsiella pneumoniae

A new study found that a multifaceted infection prevention and control intervention could at least temporarily thwart outbreaks of infections from the Klebsiella pneumoniae bacterium, a leading cause of neonatal sepsis and mortality in Africa and South Asia.

10 Mar 2026

Advancing influenza vaccine development: Sino Biological launches antigens for the 2026-2027 Northern Hemisphere influenza vaccine strains

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition.

From Sino Biological Inc. 4 Mar 2026

INTEGRA Biosciences strengthened its market position in 2025

INTEGRA Biosciences reported a successful financial year in 2025, despite exceptional economic and geopolitical challenges.

24 Feb 2026

SwRI advances safer manufacturing of nerve agent antidotes

Southwest Research Institute (SwRI) continues to expand its unique drug synthesis capabilities and expertise to advance the scalable manufacturing of safer antidotes to combat exposure to organophosphorus nerve agents (OPNAs) and pesticides.

24 Feb 2026

New gene editing approach offers hope for cystic fibrosis patients

UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells, restoring key biological function in a laboratory model of cystic fibrosis and establishing a potential new path toward mutation-agnostic gene therapy for inherited lung diseases.

17 Feb 2026

Reagents News and Research

New CellCelector CLD takes you from thousands of candidates to the top clone, faster

Semarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoption

Collaboration advances EMA601 as potential first-in-class stroke therapy

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

New AI system maps gene expression across the whole body

The new microchip electrophoresis system MultiNA II MCE-301- High sensitivity detection, improved analysis function and operability

GC product division celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics

New Legionella testing selective agar plates launched by AnalytiChem

ProImmune and the Roslin Institute collaborate to advance animal health science

Circular RNA produced by HIV boosts viral replication

Pen-strep treatment rewires mechanical sensing in immune cells

Cambridge’s LED breakthrough reinvents drug synthesis

Innovative microscopic capsules overcome long-standing limitations in single-cell research

ELRIG announces Prof Hazel Screen and Dr Dave Powell as keynote speakers for Advances in Cell-Based Screening 2026

Boron-assisted reactions overcome solubility barriers in protein synthesis

Low-cost interventions reduce neonatal sepsis from Klebsiella pneumoniae

Advancing influenza vaccine development: Sino Biological launches antigens for the 2026-2027 Northern Hemisphere influenza vaccine strains

INTEGRA Biosciences strengthened its market position in 2025

SwRI advances safer manufacturing of nerve agent antidotes

New gene editing approach offers hope for cystic fibrosis patients

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News